| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 43,452 | 39,077 | 44,285 | 57,887 | | Cost of Revenue | 29,883 | 30,686 | 32,287 | 44,412 | | | Gross Profit | 13,569 | 8,391 | 11,998 | 13,475 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,305 | 7,007 | 7,452 | 7,899 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 138 | 139 | 138 | 138 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,126 | 1,245 | 4,408 | 5,438 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,708 | 273 | 119 | 361 | | Earnings Before Interest And Taxes | 7,834 | 1,518 | 4,527 | 5,799 | | Interest Expense | 2,048 | 2,017 | 2,013 | 2,014 | | Income Before Tax | 5,786 | (499) | 2,514 | 3,785 | | Income Tax Expense | 2,003 | (127) | 930 | 1,507 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,783 | (372) | 1,584 | 2,278 | | | Non-recurring Events | | Discontinued Operations | (13) | (164) | (10) | 145 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,770 | (536) | 1,574 | 2,423 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,658 | ($536) | $1,574 | $2,423 |
|
0.03% Nasdaq 0.00%
Income Statement
